- Home
- HKIT vs RFL Comparison
HKIT vs RFL Comparison
Compare HKIT & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- RFL
- Stock Information
- Founded
- HKIT 1996
- RFL 2017
- Country
- HKIT China
- RFL United States
- Employees
- HKIT N/A
- RFL N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- RFL Real Estate
- Sector
- HKIT Technology
- RFL Finance
- Exchange
- HKIT Nasdaq
- RFL Nasdaq
- Market Cap
- HKIT 45.4M
- RFL 55.3M
- IPO Year
- HKIT 2023
- RFL N/A
- Fundamental
- Price
- HKIT $1.31
- RFL $1.92
- Analyst Decision
- HKIT
- RFL
- Analyst Count
- HKIT 0
- RFL 0
- Target Price
- HKIT N/A
- RFL N/A
- AVG Volume (30 Days)
- HKIT 24.9K
- RFL 27.8K
- Earning Date
- HKIT 12-31-2024
- RFL 12-27-2024
- Dividend Yield
- HKIT N/A
- RFL N/A
- EPS Growth
- HKIT N/A
- RFL N/A
- EPS
- HKIT 0.04
- RFL N/A
- Revenue
- HKIT $3,449,206.00
- RFL $697,000.00
- Revenue This Year
- HKIT N/A
- RFL N/A
- Revenue Next Year
- HKIT N/A
- RFL N/A
- P/E Ratio
- HKIT $34.45
- RFL N/A
- Revenue Growth
- HKIT N/A
- RFL 151.62
- 52 Week Low
- HKIT $0.54
- RFL $1.29
- 52 Week High
- HKIT $6.48
- RFL $2.50
- Technical
- Relative Strength Index (RSI)
- HKIT 43.90
- RFL 53.58
- Support Level
- HKIT $1.28
- RFL $1.71
- Resistance Level
- HKIT $1.41
- RFL $1.92
- Average True Range (ATR)
- HKIT 0.11
- RFL 0.10
- MACD
- HKIT -0.00
- RFL -0.00
- Stochastic Oscillator
- HKIT 15.28
- RFL 84.00
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.